Franklin Resources
AURA icon

Franklin Resources’s Aura Biosciences AURA Stock Holding History

Franklin Resources’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Hold
2,072,726
– – ﹤0.01% 1124
2026
Q1 		$13.9M Sell
2,072,726
-125,697
-6% -$721K ﹤0.01% 1117
2025
Q4 		$12M Sell
2,198,423
-492
-0% -$2.92K ﹤0.01% 1109
2025
Q3 		$13.6M Sell
2,198,915
-141,895
-6% -$928K ﹤0.01% 1074
2025
Q2 		$14.7M Buy
2,340,810
+130,221
+6% +$762K ﹤0.01% 1016
2025
Q1 		$13M Buy
2,210,589
+487,526
+28% +$3.69M ﹤0.01% 1023
2024
Q4 		$14.2M Buy
1,723,063
+54,103
+3% +$509K ﹤0.01% 1006
2024
Q3 		$15.6M Buy
1,668,960
+215,597
+15% +$1.85M ﹤0.01% 970
2024
Q2 		$11M Hold
1,453,363
– – ﹤0.01% 1039
2024
Q1 		$11.4M Buy
1,453,363
+853,245
+142% +$7.07M ﹤0.01% 1032
2023
Q4 		$5.32M Buy
+600,118
New +$5.08M ﹤0.01% 1100

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Franklin Resources's AURA Position: Q2 2026 in Review

Franklin Resources held its Aura Biosciences (AURA) position steady in Q2 2026 at 2,072,726 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

Franklin Resources first reported a position in AURA in Q4 2023 and has held it in 11 quarters since. The position peaked at $15.6M in Q3 2024. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Franklin Resources held 2,072,726 shares of Aura Biosciences worth $14.7M as of Q2 2026.
  • Franklin Resources left its Aura Biosciences share count unchanged in Q2 2026.
  • Aura Biosciences made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1124 holding.
  • Franklin Resources first reported a position in Aura Biosciences in Q4 2023 and has held it in 11 quarters since.
  • Franklin Resources's Aura Biosciences position peaked at $15.6M in Q3 2024.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.